Johns Hopkins scientists have engineered cells that behave like AND and OR Boolean logic gates, producing an output based on one or more unique inputs.

A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients.

PARIS, May 17, 2012 /PRNewswire/ -- OrbusNeich today announced that two subgroup analyses from the REMEDEE trial assessing vascular healing of the company's Combo Dual Therapy Stent versus

Randomized Evaluation of an abluMinal sirolimus coatED bio-Engineered stE

Basis for the epilepsy-autism connection is found - and may be reversible with an existing drug BOSTON, May 2, 2012 /PRNewswire-USNewswire/